Medifast Q2 2021 revenue $394.2M (+79% YoY), EPS $3.96; FY guidance $1.425-1.525B

MEDIFAST INC

2021-Q2 EPS reported $7.42 revenue$734,858,000

Revenue $394.2M, up 79.2% YoY; net income $47M (+114.1%); diluted EPS $3.96 (+112.9%).
Active OPTA VIA coaches 59,200 (+62.2%); revenue per coach $6,662 (+13.9%).
Gross margin 74.5% vs 72.4%; operating income $61.4M, up 118.5%
FY2021 guidance: revenue $1.425-1.525B, EPS $12.70-14.17.
Declared $1.42/sh dividend (pay Aug 6); $12.2M share repurchases; $125M credit facility undrawn.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.